Switch to:
Also traded in: Germany

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 2/10

vs
industry
vs
history
Cash-to-Debt 0.68
TNDM's Cash-to-Debt is ranked lower than
70% of the 325 Companies
in the Global Medical Devices industry.

( Industry Median: 2.55 vs. TNDM: 0.68 )
Ranked among companies with meaningful Cash-to-Debt only.
TNDM' s Cash-to-Debt Range Over the Past 10 Years
Min: 0.67  Med: 2.36 Max: 4.41
Current: 0.68
0.67
4.41
Equity-to-Asset -0.05
TNDM's Equity-to-Asset is ranked lower than
94% of the 300 Companies
in the Global Medical Devices industry.

( Industry Median: 0.63 vs. TNDM: -0.05 )
Ranked among companies with meaningful Equity-to-Asset only.
TNDM' s Equity-to-Asset Range Over the Past 10 Years
Min: -2.66  Med: 0.51 Max: 0.71
Current: -0.05
-2.66
0.71
Piotroski F-Score: 2
Altman Z-Score: -5.62
Beneish M-Score: -3.79
WACC vs ROIC
7.78%
-387.44%
WACC
ROIC
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 2/10

vs
industry
vs
history
Operating Margin % -92.64
TNDM's Operating Margin % is ranked lower than
77% of the 304 Companies
in the Global Medical Devices industry.

( Industry Median: 2.62 vs. TNDM: -92.64 )
Ranked among companies with meaningful Operating Margin % only.
TNDM' s Operating Margin % Range Over the Past 10 Years
Min: -1335.27  Med: -152.17 Max: -92.64
Current: -92.64
-1335.27
-92.64
Net Margin % -99.05
TNDM's Net Margin % is ranked lower than
77% of the 304 Companies
in the Global Medical Devices industry.

( Industry Median: 1.55 vs. TNDM: -99.05 )
Ranked among companies with meaningful Net Margin % only.
TNDM' s Net Margin % Range Over the Past 10 Years
Min: -1333.94  Med: -159.94 Max: -99.05
Current: -99.05
-1333.94
-99.05
ROE % -296.42
TNDM's ROE % is ranked lower than
97% of the 300 Companies
in the Global Medical Devices industry.

( Industry Median: 1.31 vs. TNDM: -296.42 )
Ranked among companies with meaningful ROE % only.
TNDM' s ROE % Range Over the Past 10 Years
Min: -1331.34  Med: -206.37 Max: -93.5
Current: -296.42
-1331.34
-93.5
ROA % -74.87
TNDM's ROA % is ranked lower than
84% of the 327 Companies
in the Global Medical Devices industry.

( Industry Median: 0.06 vs. TNDM: -74.87 )
Ranked among companies with meaningful ROA % only.
TNDM' s ROA % Range Over the Past 10 Years
Min: -182.5  Med: -66.52 Max: -59.2
Current: -74.87
-182.5
-59.2
ROC (Joel Greenblatt) % -321.76
TNDM's ROC (Joel Greenblatt) % is ranked lower than
76% of the 323 Companies
in the Global Medical Devices industry.

( Industry Median: 4.26 vs. TNDM: -321.76 )
Ranked among companies with meaningful ROC (Joel Greenblatt) % only.
TNDM' s ROC (Joel Greenblatt) % Range Over the Past 10 Years
Min: -598.61  Med: -462.37 Max: -308.73
Current: -321.76
-598.61
-308.73
3-Year Revenue Growth Rate -34.60
TNDM's 3-Year Revenue Growth Rate is ranked lower than
90% of the 237 Companies
in the Global Medical Devices industry.

( Industry Median: 4.40 vs. TNDM: -34.60 )
Ranked among companies with meaningful 3-Year Revenue Growth Rate only.
TNDM' s 3-Year Revenue Growth Rate Range Over the Past 10 Years
Min: 0  Med: -42.4 Max: -34.6
Current: -34.6
3-Year EBITDA Growth Rate -49.90
TNDM's 3-Year EBITDA Growth Rate is ranked lower than
95% of the 208 Companies
in the Global Medical Devices industry.

( Industry Median: 5.10 vs. TNDM: -49.90 )
Ranked among companies with meaningful 3-Year EBITDA Growth Rate only.
TNDM' s 3-Year EBITDA Growth Rate Range Over the Past 10 Years
Min: -75.6  Med: -72 Max: -49.9
Current: -49.9
-75.6
-49.9
3-Year EPS without NRI Growth Rate -49.70
TNDM's 3-Year EPS without NRI Growth Rate is ranked lower than
92% of the 203 Companies
in the Global Medical Devices industry.

( Industry Median: 1.40 vs. TNDM: -49.70 )
Ranked among companies with meaningful 3-Year EPS without NRI Growth Rate only.
TNDM' s 3-Year EPS without NRI Growth Rate Range Over the Past 10 Years
Min: -75.8  Med: -71.6 Max: -49.7
Current: -49.7
-75.8
-49.7
GuruFocus has detected 3 Warning Signs with Tandem Diabetes Care Inc $TNDM.
More than 500,000 people have already joined GuruFocus to track the stocks they follow and exchange investment ideas.
» TNDM's 10-Y Financials

Financials (Next Earnings Date: 2017-06-08 Est.)


Revenue & Net Income
Cash & Debt
Operating Cash Flow & Free Cash Flow
Operating Cash Flow & Net Income

» Details

Guru Trades

Q1 2016

TNDM Guru Trades in Q1 2016

Jim Simons 239,300 sh (+45.65%)
Steven Cohen 825,000 sh (+3.54%)
John Paulson 540,000 sh (unchged)
» More
Q2 2016

TNDM Guru Trades in Q2 2016

Jim Simons 294,300 sh (+22.98%)
Steven Cohen 850,000 sh (+3.03%)
» More
Q3 2016

TNDM Guru Trades in Q3 2016

Jim Simons 356,400 sh (+21.10%)
Steven Cohen 983,514 sh (+15.71%)
» More
Q4 2016

TNDM Guru Trades in Q4 2016

Steven Cohen Sold Out
Jim Simons 304,400 sh (-14.59%)
» More
» Details

Insider Trades

Latest Guru Trades with TNDM

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found in the selected group of Gurus. You can
  • 1. Modify your Personalized List of Gurus, or
  • 2. Click on Premium Premium Tools above to check out all the Gurus, or
  • 3. Click on Premium Plus Premium Plus above for the stocks picks of all the institutional investment advisors (>4000)
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Business Description

Industry: Medical Devices » Medical Devices    NAICS: 339112    SIC: 3841
Compare:OTCPK:TITXF, NAS:AVGR, OTCPK:BLOZF, OTCPK:IVOB, OTCPK:BTCY, OTCPK:AVMXF, AMEX:ELMD, OTCPK:QTVLF, NAS:ETRM, OTCPK:DIZTF, NAS:MGCD, NAS:SRTS, NAS:SPAN, OTCPK:BSGM, NAS:RWLK, NAS:KOOL, OTCPK:VICA, OTCPK:TLTFF, NAS:PAVM, OTCPK:ZMSPF » details
Traded in other countries:TD5.Germany,
Headquarter Location:USA
Tandem Diabetes Care, Inc. is a medical device company engaged in the designing, development and commercialization of products for people with insulin-dependent diabetes. The Company's flagship product is the t:slim Insulin Delivery System.

Ratios

vs
industry
vs
history
PS Ratio 0.39
TNDM's PS Ratio is ranked higher than
93% of the 296 Companies
in the Global Medical Devices industry.

( Industry Median: 3.20 vs. TNDM: 0.39 )
Ranked among companies with meaningful PS Ratio only.
TNDM' s PS Ratio Range Over the Past 10 Years
Min: 0.22  Med: 2.7 Max: 6.32
Current: 0.39
0.22
6.32
EV-to-EBIT -1.16
TNDM's EV-to-EBIT is ranked lower than
99.99% of the 275 Companies
in the Global Medical Devices industry.

( Industry Median: 24.54 vs. TNDM: -1.16 )
Ranked among companies with meaningful EV-to-EBIT only.
TNDM' s EV-to-EBIT Range Over the Past 10 Years
Min: -7.4  Med: -3.3 Max: 0.6
Current: -1.16
-7.4
0.6
EV-to-EBITDA -1.23
TNDM's EV-to-EBITDA is ranked lower than
99.99% of the 300 Companies
in the Global Medical Devices industry.

( Industry Median: 19.31 vs. TNDM: -1.23 )
Ranked among companies with meaningful EV-to-EBITDA only.
TNDM' s EV-to-EBITDA Range Over the Past 10 Years
Min: -7.8  Med: -3.5 Max: 0.6
Current: -1.23
-7.8
0.6
Current Ratio 2.93
TNDM's Current Ratio is ranked higher than
60% of the 321 Companies
in the Global Medical Devices industry.

( Industry Median: 2.38 vs. TNDM: 2.93 )
Ranked among companies with meaningful Current Ratio only.
TNDM' s Current Ratio Range Over the Past 10 Years
Min: 0.59  Med: 3.48 Max: 10.21
Current: 2.93
0.59
10.21
Quick Ratio 2.25
TNDM's Quick Ratio is ranked higher than
58% of the 321 Companies
in the Global Medical Devices industry.

( Industry Median: 1.79 vs. TNDM: 2.25 )
Ranked among companies with meaningful Quick Ratio only.
TNDM' s Quick Ratio Range Over the Past 10 Years
Min: 0.59  Med: 2.81 Max: 9.5
Current: 2.25
0.59
9.5
Days Inventory 124.59
TNDM's Days Inventory is ranked higher than
53% of the 289 Companies
in the Global Medical Devices industry.

( Industry Median: 130.04 vs. TNDM: 124.59 )
Ranked among companies with meaningful Days Inventory only.
TNDM' s Days Inventory Range Over the Past 10 Years
Min: 116.18  Med: 117.75 Max: 298.88
Current: 124.59
116.18
298.88
Days Sales Outstanding 48.40
TNDM's Days Sales Outstanding is ranked higher than
79% of the 272 Companies
in the Global Medical Devices industry.

( Industry Median: 68.94 vs. TNDM: 48.40 )
Ranked among companies with meaningful Days Sales Outstanding only.
TNDM' s Days Sales Outstanding Range Over the Past 10 Years
Min: 48.4  Med: 66.68 Max: 355.71
Current: 48.4
48.4
355.71
Days Payable 45.21
TNDM's Days Payable is ranked lower than
64% of the 259 Companies
in the Global Medical Devices industry.

( Industry Median: 59.71 vs. TNDM: 45.21 )
Ranked among companies with meaningful Days Payable only.
TNDM' s Days Payable Range Over the Past 10 Years
Min: 20.64  Med: 41.29 Max: 161.64
Current: 45.21
20.64
161.64

Buy Back

vs
industry
vs
history
3-Year Average Share Buyback Ratio -10.70
TNDM's 3-Year Average Share Buyback Ratio is ranked lower than
69% of the 218 Companies
in the Global Medical Devices industry.

( Industry Median: -3.90 vs. TNDM: -10.70 )
Ranked among companies with meaningful 3-Year Average Share Buyback Ratio only.
TNDM' s 3-Year Average Share Buyback Ratio Range Over the Past 10 Years
Min: -444  Med: -418.2 Max: -10.7
Current: -10.7
-444
-10.7

Valuation & Return

vs
industry
vs
history
Price-to-Median-PS-Value 0.14
TNDM's Price-to-Median-PS-Value is ranked higher than
95% of the 242 Companies
in the Global Medical Devices industry.

( Industry Median: 1.03 vs. TNDM: 0.14 )
Ranked among companies with meaningful Price-to-Median-PS-Value only.
TNDM' s Price-to-Median-PS-Value Range Over the Past 10 Years
Min: 0.1  Med: 1.01 Max: 2.19
Current: 0.14
0.1
2.19
Earnings Yield (Greenblatt) % -85.42
TNDM's Earnings Yield (Greenblatt) % is ranked lower than
97% of the 432 Companies
in the Global Medical Devices industry.

( Industry Median: 2.17 vs. TNDM: -85.42 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) % only.
TNDM' s Earnings Yield (Greenblatt) % Range Over the Past 10 Years
Min: -90.91  Med: 220 Max: 491.7
Current: -85.42
-90.91
491.7

More Statistics

Revenue (TTM) (Mil) $84.25
EPS (TTM) $ -2.73
Beta0.51
Short Percentage of Float5.98%
52-Week Range $0.94 - 11.30
Shares Outstanding (Mil)49.84

Analyst Estimate

Dec17 Dec18 Dec19
Revenue (Mil $) 110 153 208
EPS ($) -2.23 -1.48 -0.27
EPS without NRI ($) -2.23 -1.48 -0.27
EPS Growth Rate
(Future 3Y To 5Y Estimate)
N/A
Dividends per Share ($)
» More Articles for TNDM

Headlines

Articles On GuruFocus.com
No related article found.

More From Other Websites
Tandem Diabetes Care to Present at the Deutsche Bank 42nd Annual Health Care Conference Apr 19 2017
Tandem Diabetes Care Schedules First Quarter 2017 Earnings Press Release and Conference Call Apr 13 2017
ETFs with exposure to Tandem Diabetes Care, Inc. : April 11, 2017 Apr 11 2017
Tandem Diabetes Care Launches New t:connect Diabetes Management Application Portal for Healthcare... Apr 11 2017
Windstream, Gulfport Energy in Thursday’s 52-Week Low Club Mar 23 2017
2 Health Care Stocks Crushed on Thursday Mar 23 2017
Implied Volatility Surging for Tandem (TNDM) Stock Options Mar 23 2017
Tandem Diabetes Care Announces Pricing of Underwritten Public Offering of Common Stock Mar 23 2017
Tandem Diabetes Care, Inc. :TNDM-US: Earnings Analysis: Q4, 2016 By the Numbers : March 17, 2017 Mar 17 2017
Tandem Diabetes Care, Inc. :TNDM-US: Earnings Analysis: 2016 By the Numbers : March 15, 2017 Mar 15 2017
Edited Transcript of TNDM earnings conference call or presentation 8-Mar-17 9:30pm GMT Mar 08 2017
Tandem Diabetes Care Announces Filing of Registration Statement for Proposed Follow-on Public... Mar 08 2017
Tandem Diabetes reports 4Q loss Mar 08 2017
Tandem Diabetes Care Reports 2016 Financial Results Mar 08 2017
Tandem Diabetes Care Announces Plans for Improved Infusion Set Connector Developed from Customer... Mar 08 2017
Tandem Diabetes Care Launches First Ever Remote Software Update for Insulin Pump using a Personal... Mar 02 2017
Tandem Diabetes Care Schedules Fourth Quarter and Full Year 2016 Earnings Press Release and... Feb 21 2017
Data Presented at ATTD 2017 Demonstrate Clinical Advantages of Tandem Diabetes Care Sensor-augmented... Feb 15 2017
Biotech Industry Outperforming Markets in 2017: Latest Reports on Benitec Biopharma and Tandem... Jan 18 2017
DexCom Jumps 25% As It Becomes Only Continuous Glucose Monitoring With Medicare Coverage Jan 13 2017

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)